Nutrix: From early IP foundations to hormone intelligence at scale

Nutrix is a Swiss healthtech venture building “hormone intelligence” – combining AI-driven coaching with non-invasive hormone monitoring to make prevention and chronic-care support more precise, more personal, and easier to scale. The goal is simple: help people understand what’s happening in their bodies earlier, then support them with actionable guidance that fits daily life.

Nutrix’s progress has been shaped by a long-term journey through the Basel Area Life Sciences Supercluster – with Basel Area Business & Innovation supporting key steps from early-stage foundations through acceleration, and Switzerland Innovation Park Basel Area providing a base to keep building.

What Nutrix is building – and why it matters for patients

Nutrix brings together software and biosensing to turn complex biological signals into practical, patient-friendly insights.

At the center is gSense, Nutrix’s AI software platform. It collects health and lifestyle data and translates it into personalized coaching and support – helping people follow a plan, understand progress, and stay engaged over time. For patients, the benefit is straightforward: clearer insight, better adherence, and more confidence in day-to-day health decisions.

“Imagine gSense as your personal health assistant. It takes information about your lab test results, physical activity and body composition. We analyze all this data and provide personalized coaching and medical awareness support for users,” says Maria Hahn, Co-Founder and CEO of Nutrix.

Alongside gSense is Nutrix’s biosensor work, including cortiSense – described as the first non-invasive salivary cortisol monitor, recognized with a CES Innovation Award 2025, plus tSense for testosterone, which earned a second consecutive CES Innovation Award in 2026. Cortisol is often called the “stress hormone,” and Nutrix’s ambition is to make it measurable in a patient-friendly way, so people can understand physiological stress patterns earlier and act before they compound into bigger health issues.

“What’s very unique is that we have both software and hardware,” says Maria. “We’re adding cortiSense, a hormone monitoring platform that enables non-invasive, fast, precise hormone monitoring at home.”

The challenge: building at the intersection of biology, hardware, and behavior change

Building a healthtech company that spans biology, hardware development, data science, and patient engagement comes with a specific set of challenges. Early decisions matter – especially when it comes to:

  • protecting core intellectual property,
  • finding trusted experts and service partners,
  • building credibility with stakeholders, and
  • staying close to an ecosystem that can accelerate progress.

That combination makes “the right support at the right moment” a competitive advantage, and it’s where Nutrix’s journey with Basel Area Business & Innovation began.

Nutrix’s journey with us: from early foundations to acceleration

Maria’s path to building Nutrix is also a story about choosing a region and ecosystem early.

“I’m originally from Poland. I have lived in Switzerland for 11 years and I’m based in Basel,” she says. “When I thought about launching my company, I investigated partners who could help and be on this journey with us. Basel Area Business & Innovation was a frictionless solution, and this is how we started.”

2019: Venture Mentoring – getting the IP foundations right

Nutrix’s collaboration with BA began with early-stage support through what was at that time called its Venture Mentoring service (now known as VentureConnect), including input on intellectual property and patent strategy – helping the team put strong foundations in place at a formative stage.

“It was great to have the possibility to interact with patent expert so early in the development of our project. During the Venture Mentoring workshop, we had good discussion and created solid base for the future patent strategy,” recalls Maria.

2020: DayOne Accelerator – sharper focus, stronger connections

In 2020, Nutrix joined the DayOne Accelerator cohort. “DayOne allowed us to connect with partners that still work with us today.”

Those connections stayed practical and enduring. “We met our patent attorney there who protects our technology. We met the finance and accounting team there. We also have our core coaching with Innosuisse and we work with the same coach we met during the initial incubation phase.”

2021: Continuing the journey with SIP: a base to keep building

In 2021, Nutrix became a resident at Switzerland Innovation Park Basel Area – Novartis Campus, and the team has continued to build from there ever since.

“We moved to the office at the Novartis Campus in 2021 and we kept developing our technology from that moment on.”

Today, Nutrix remains a resident on the Novartis Campus with a setup that provides flexibility while keeping the team closely connected to the wider ecosystem.

What changed along the way: expertise, partners and momentum

Nutrix’s story goes beyond being about product development. It’s also about reducing “unknowns” at each stage.

  • Clarity early on: IP strategy support helped set direction at a crucial moment.
  • Stronger delivery readiness: access to trusted partners (legal, finance, coaching) reduced operational friction.
  • More real-world feedback loops: being able to share the technology, get input, and iterate faster strengthened the solution.

“I like the ecosystem for innovation,” Maria says. “Truly innovative products and services require talent and conversation, enriching conversation.”

“We also had the possibility to present our technology here in Basel during events, get feedback, get the conversation going,” she adds. “That helps us create a better solution.”

Looking ahead: from startup to scale-up

Nutrix describes itself as being “in a transition phase from startup to scale-up. We already provide the service, have already created positive impact, and possess validated clinical healthcare outcomes of our platform.”

Now the focus is on “building the manufacturing site to provide our hormone monitoring platform at scale, to many people globally.”

Nutrix has five patents pending and is expanding across Latin America, Japan and the US – while continuing to build from Basel.

About the expert

Maria Hahn is the Co-Founder and CEO of Nutrix, a Basel-based healthtech company combining AI-driven coaching with hormone-monitoring biosensors to make prevention and chronic-care support more precise and scalable. Originally from Poland, Maria has been based in Switzerland for more than a decade and has led Nutrix from early development through acceleration and into its current scale-up phase.

Building a scalable venture in science or tech?

If you’re building a startup or scale-up in science and tech and want hands-on support to launch in the Basel Area, we can help – from early foundations (like IP and strategy) to acceleration, connections and growth support. Check out our Launch service offerings!